Birth-death processes with piecewise constant ratesKOPP-SCHNEIDER, A.Statistics & probability letters. 1992, Vol 13, Num 2, pp 121-127, issn 0167-7152Article

Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skinFÜRSTENBERGER, G; KOPP-SCHNEIDER, A.Carcinogenesis (New York. Print). 1995, Vol 16, Num 1, pp 61-69, issn 0143-3334Article

A stem cell model for carcinogenesisKOPP-SCHNEIDER, A; PORTIER, C. J.Mathematical biosciences. 1994, Vol 120, Num 2, pp 211-232, issn 0025-5564Article

Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delayLUTZ, W. K; KOPP-SCHNEIDER, A.Toxicological sciences (Print). 1999, Vol 49, Num 1, pp 110-115, issn 1096-6080Article

Carcinoma formation of NMRI mouse skin painting studies is a process suggesting greater than two stagesKOPP-SCHNEIDER, A; PORTIER, C. J.Carcinogenesis (New York. Print). 1995, Vol 16, Num 1, pp 53-59, issn 0143-3334Article

The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experimentsKOPP-SCHNEIDER, A; PORTIER, C. J; RIPPMANN, F et al.Mathematical biosciences. 1991, Vol 105, Num 2, pp 139-166, issn 0025-5564, 28 p.Article

Distinguishing between models of carcinogenesis : the role of clonal expansionKOPP-SCHNEIDER, A; PORTIER, C. J.Fundamental and applied toxicology (Print). 1991, Vol 17, Num 3, pp 601-613, issn 0272-0590Article

A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic eventsKOPP-SCHNEIDER, A; PORTIER, C; BANNASCH, P et al.Mathematical biosciences. 1998, Vol 148, Num 2, pp 181-204, issn 0025-5564Article

Birth and death/differentiation rates of papillomas in mouse skinKOPP-SCHNEIDER, A; PORTIER, C. J.Carcinogenesis (New York. Print). 1992, Vol 13, Num 6, pp 973-978, issn 0143-3334Article

Using a stochastic model to analyze the sequence of phenotypic changes in rat liver focal lesionsKOPP-SCHNEIDER, A.Mathematical and computer modelling. 2001, Vol 33, Num 12-13, pp 1289-1295, issn 0895-7177Article

Multistage, stochastic models of the cancer process : A general theory for calculating tumor incidencePORTIER, C. J; SHERMAN, C. D; KOPP-SCHNEIDER, A et al.Stochastic environmental research and risk assessment (Print). 2000, Vol 14, Num 3, pp 173-179, issn 1436-3240Article

Calculating tumor incidence rates in stochastic models of carcinogenesisPORTIER, C. J; KOPP-SCHNEIDER, A; SHERMAN, C. D et al.Mathematical biosciences. 1996, Vol 135, Num 2, pp 129-146, issn 0025-5564Article

Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instabilityZERBAN, H; RADIG, S; KOPP-SCHNEIDER, A et al.Carcinogenesis (New York. Print). 1994, Vol 15, Num 11, pp 2467-2473, issn 0143-3334Article

Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholineSTRÖBEL, P; KLIMEK, F; ZERBAN, H et al.Carcinogenesis (New York. Print). 1998, Vol 19, Num 12, pp 2069-2080, issn 0143-3334Article

Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: Comparison of genomic and proteomic responses and anchoring to histopathological parametersOBEREMM, A; AHR, H.-J; KRÖGER, M et al.Toxicology and applied pharmacology. 2009, Vol 241, Num 2, pp 230-245, issn 0041-008X, 16 p.Article

Statistical models for low dose exposureEDLER, L; KOPP-SCHNEIDER, A.Mutation research. 1998, Vol 405, Num 2, pp 227-236, issn 0027-5107Conference Paper

Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesisENZMANN, H; ZERBAN, H; KOPP-SCHNEIDER, A et al.Carcinogenesis (New York. Print). 1995, Vol 16, Num 7, pp 1513-1518, issn 0143-3334Article

Identification of human renal cell carcinoma associated genes by suppression subtractive hybridizationSTASSAR, M. J. J. G; DEVITT, G; BROSIUS, M et al.British journal of cancer. 2001, Vol 85, Num 9, pp 1372-1382, issn 0007-0920Article

C4.4A as a candidate marker in the diagnosis of colorectal cancerPARET, C; HILDEBRAND, D; WEITZ, J et al.British journal of cancer. 2007, Vol 97, Num 8, pp 1146-1156, issn 0007-0920, 11 p.Article

Magnetic resonance-compatible-spirometry : principle, technical evaluation and applicationEICHINGER, M; PUDERBACH, M; SMITH, H-J et al.The European respiratory journal. 2007, Vol 30, Num 5, pp 972-979, issn 0903-1936, 8 p.Article

Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphismROJAS, M; CASCORBI, I; ALEXANDROV, K et al.Carcinogenesis (New York. Print). 2000, Vol 21, Num 1, pp 35-41, issn 0143-3334Article

Porphyrin studies in TCDD-exposed workersJUNG, D; KONIETZKO, J; REILL-KONIETZKO, G et al.Archives of toxicology. 1994, Vol 68, Num 9, pp 595-598, issn 0340-5761Article

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinomaCHARIYALERTSAK, S; SIRIKULCHAYANONTA, V; MAYER, D et al.Gut. 2001, Vol 48, Num 1, pp 80-86, issn 0017-5749Article

Mutational activation of the β-catenin proto-oncogene is a common event in the development of Wilms' tumorsKOESTERS, R; RIDDER, R; KOPP-SCHNEIDER, A et al.Cancer research (Baltimore). 1999, Vol 59, Num 16, pp 3880-3882, issn 0008-5472Article

High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1 *0/*0 genotypesROJAS, M; ALEXANDROV, K; ROOTS, I et al.Pharmacogenetics (London). 1998, Vol 8, Num 2, pp 109-118, issn 0960-314XArticle